Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer

Sara H. Javid, Amy Moran, Adelaide M. Carothers, Mark Redston, Monica M. Bertagnolli

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Epidemiological studies suggest that post-menopausal hormone replacement therapy (HRT) reduces colorectal cancer (CRC) incidence. Phytoestrogens, including the soy isoflavone genistein and coumestrol, are used by many women as alternatives to HRT. Previous studies showed that ovariectomy induced a 77% increase in intestinal adenoma number in the C57BL/6J-Min/+ (Min/+) mouse, an animal model of adenomatous polyposis coli (APC)-associated CRC. Replacement of estradiol (E2) in ovariectomized Min/+ mice reduced tumor number to baseline and up-regulated the expression of estrogen receptor β (ERβ). We hypothesized that the phytoestrogens genistein and coumestrol would inhibit intestinal tumorigenesis in ovariectomized Min/+ mice. Min/+ and Apc +/+ (WT) mice were ovariectomized and assigned to either a control diet or treatment with E2, genistein or coumestrol. Treatment of ovariectomized Min/+ (Min/+ OX) mice with genistein resulted in a non-significant reduction in tumor number. Min/+ OX mice treated with coumestrol had significantly fewer tumors than untreated Min/+ OX controls and the same number of tumors as non-ovariectomized Min/+ mice. Bromodeoxyuridine migration assays also demonstrated that treatment with E2 or coumestrol improved enterocyte migration rate. Immunoprecipitation and immunohistochemistry analyses showed that impaired association of the adherens junction proteins E-cadherin and β-catenin in Min/+ mice was improved by treatment with either E2 or coumestrol. Immunoblot analyses also showed that expression of ERβ was elevated in enterocytes of Min/+ OX mice treated with E2 or coumestrol as compared with those of untreated Min/+ OX mice. In conclusion, both coumestrol and E2 prevent intestinal tumorigenesis and ameliorate enterocyte migration and intercellular adhesion in the ApcMin/+ mouse model of CRC.

Original languageEnglish (US)
Pages (from-to)587-595
Number of pages9
JournalCarcinogenesis
Volume26
Issue number3
DOIs
StatePublished - Sep 6 2005
Externally publishedYes

Fingerprint

Coumestrol
Cell Movement
Colorectal Neoplasms
Estrogens
Genistein
Neoplasms
Enterocytes
Phytoestrogens
Estrogen Receptors
Carcinogenesis
Adherens Junctions
Catenins
Adenomatous Polyposis Coli
Estrogen Replacement Therapy
Isoflavones
Hormone Replacement Therapy
Ovariectomy
Bromodeoxyuridine
Cadherins
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer. / Javid, Sara H.; Moran, Amy; Carothers, Adelaide M.; Redston, Mark; Bertagnolli, Monica M.

In: Carcinogenesis, Vol. 26, No. 3, 06.09.2005, p. 587-595.

Research output: Contribution to journalArticle

Javid, Sara H. ; Moran, Amy ; Carothers, Adelaide M. ; Redston, Mark ; Bertagnolli, Monica M. / Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer. In: Carcinogenesis. 2005 ; Vol. 26, No. 3. pp. 587-595.
@article{6742fb972be842e8a7f3500a90ad2c31,
title = "Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer",
abstract = "Epidemiological studies suggest that post-menopausal hormone replacement therapy (HRT) reduces colorectal cancer (CRC) incidence. Phytoestrogens, including the soy isoflavone genistein and coumestrol, are used by many women as alternatives to HRT. Previous studies showed that ovariectomy induced a 77{\%} increase in intestinal adenoma number in the C57BL/6J-Min/+ (Min/+) mouse, an animal model of adenomatous polyposis coli (APC)-associated CRC. Replacement of estradiol (E2) in ovariectomized Min/+ mice reduced tumor number to baseline and up-regulated the expression of estrogen receptor β (ERβ). We hypothesized that the phytoestrogens genistein and coumestrol would inhibit intestinal tumorigenesis in ovariectomized Min/+ mice. Min/+ and Apc +/+ (WT) mice were ovariectomized and assigned to either a control diet or treatment with E2, genistein or coumestrol. Treatment of ovariectomized Min/+ (Min/+ OX) mice with genistein resulted in a non-significant reduction in tumor number. Min/+ OX mice treated with coumestrol had significantly fewer tumors than untreated Min/+ OX controls and the same number of tumors as non-ovariectomized Min/+ mice. Bromodeoxyuridine migration assays also demonstrated that treatment with E2 or coumestrol improved enterocyte migration rate. Immunoprecipitation and immunohistochemistry analyses showed that impaired association of the adherens junction proteins E-cadherin and β-catenin in Min/+ mice was improved by treatment with either E2 or coumestrol. Immunoblot analyses also showed that expression of ERβ was elevated in enterocytes of Min/+ OX mice treated with E2 or coumestrol as compared with those of untreated Min/+ OX mice. In conclusion, both coumestrol and E2 prevent intestinal tumorigenesis and ameliorate enterocyte migration and intercellular adhesion in the ApcMin/+ mouse model of CRC.",
author = "Javid, {Sara H.} and Amy Moran and Carothers, {Adelaide M.} and Mark Redston and Bertagnolli, {Monica M.}",
year = "2005",
month = "9",
day = "6",
doi = "10.1093/carcin/bgh346",
language = "English (US)",
volume = "26",
pages = "587--595",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer

AU - Javid, Sara H.

AU - Moran, Amy

AU - Carothers, Adelaide M.

AU - Redston, Mark

AU - Bertagnolli, Monica M.

PY - 2005/9/6

Y1 - 2005/9/6

N2 - Epidemiological studies suggest that post-menopausal hormone replacement therapy (HRT) reduces colorectal cancer (CRC) incidence. Phytoestrogens, including the soy isoflavone genistein and coumestrol, are used by many women as alternatives to HRT. Previous studies showed that ovariectomy induced a 77% increase in intestinal adenoma number in the C57BL/6J-Min/+ (Min/+) mouse, an animal model of adenomatous polyposis coli (APC)-associated CRC. Replacement of estradiol (E2) in ovariectomized Min/+ mice reduced tumor number to baseline and up-regulated the expression of estrogen receptor β (ERβ). We hypothesized that the phytoestrogens genistein and coumestrol would inhibit intestinal tumorigenesis in ovariectomized Min/+ mice. Min/+ and Apc +/+ (WT) mice were ovariectomized and assigned to either a control diet or treatment with E2, genistein or coumestrol. Treatment of ovariectomized Min/+ (Min/+ OX) mice with genistein resulted in a non-significant reduction in tumor number. Min/+ OX mice treated with coumestrol had significantly fewer tumors than untreated Min/+ OX controls and the same number of tumors as non-ovariectomized Min/+ mice. Bromodeoxyuridine migration assays also demonstrated that treatment with E2 or coumestrol improved enterocyte migration rate. Immunoprecipitation and immunohistochemistry analyses showed that impaired association of the adherens junction proteins E-cadherin and β-catenin in Min/+ mice was improved by treatment with either E2 or coumestrol. Immunoblot analyses also showed that expression of ERβ was elevated in enterocytes of Min/+ OX mice treated with E2 or coumestrol as compared with those of untreated Min/+ OX mice. In conclusion, both coumestrol and E2 prevent intestinal tumorigenesis and ameliorate enterocyte migration and intercellular adhesion in the ApcMin/+ mouse model of CRC.

AB - Epidemiological studies suggest that post-menopausal hormone replacement therapy (HRT) reduces colorectal cancer (CRC) incidence. Phytoestrogens, including the soy isoflavone genistein and coumestrol, are used by many women as alternatives to HRT. Previous studies showed that ovariectomy induced a 77% increase in intestinal adenoma number in the C57BL/6J-Min/+ (Min/+) mouse, an animal model of adenomatous polyposis coli (APC)-associated CRC. Replacement of estradiol (E2) in ovariectomized Min/+ mice reduced tumor number to baseline and up-regulated the expression of estrogen receptor β (ERβ). We hypothesized that the phytoestrogens genistein and coumestrol would inhibit intestinal tumorigenesis in ovariectomized Min/+ mice. Min/+ and Apc +/+ (WT) mice were ovariectomized and assigned to either a control diet or treatment with E2, genistein or coumestrol. Treatment of ovariectomized Min/+ (Min/+ OX) mice with genistein resulted in a non-significant reduction in tumor number. Min/+ OX mice treated with coumestrol had significantly fewer tumors than untreated Min/+ OX controls and the same number of tumors as non-ovariectomized Min/+ mice. Bromodeoxyuridine migration assays also demonstrated that treatment with E2 or coumestrol improved enterocyte migration rate. Immunoprecipitation and immunohistochemistry analyses showed that impaired association of the adherens junction proteins E-cadherin and β-catenin in Min/+ mice was improved by treatment with either E2 or coumestrol. Immunoblot analyses also showed that expression of ERβ was elevated in enterocytes of Min/+ OX mice treated with E2 or coumestrol as compared with those of untreated Min/+ OX mice. In conclusion, both coumestrol and E2 prevent intestinal tumorigenesis and ameliorate enterocyte migration and intercellular adhesion in the ApcMin/+ mouse model of CRC.

UR - http://www.scopus.com/inward/record.url?scp=16244385306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244385306&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh346

DO - 10.1093/carcin/bgh346

M3 - Article

C2 - 15579483

AN - SCOPUS:16244385306

VL - 26

SP - 587

EP - 595

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 3

ER -